GNCA

Genocea Biosciences, Inc.
GNCA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

34 hedge funds and large institutions have $29.4M invested in Genocea Biosciences, Inc. in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

26% less capital invested

Capital invested by funds: $39.8M → $29.4M (-$10.5M)

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.13M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$158K
2
+$140K
3
+$126K
4
ECM
Endurant Capital Management
California
+$104K
5
KCM
Kingdon Capital Management
New York
+$96.9K

Top Sellers

1
-$151K
2
-$123K
3
-$31.4K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$31K
5
AA
AlphaMark Advisors
Kentucky
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$27K
27
$21K
28
$11K
29
$5K
30
$3K
31
$2.35K
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
1
2